Serial Monitoring of Circulating Tumour DNA on Clinical Outcome in Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Overview

Journal Clin Transl Med

Publisher Wiley

Specialty General Medicine

Date 2023 Jul 26

PMID 37491737

Authors

Xinping Zhou

Wei Lang

Chen Mei

Yanling Ren

Liya Ma

Lingxu Jiang

Li Ye

Gaixiang Xu

Yingwan Luo

Lixia Liu

Shanbo Cao

Jiayue Qin

Hongyan Tong

Affiliations

Soon will be listed here.

Citing Articles

Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives.

Zhang L, Deeb G, Deeb K, Vale C, Peker Barclift D, Papadantonakis N Cancers (Basel). 2024; 16(8).

PMID: 38672585 PMC: 11048433. DOI: 10.3390/cancers16081503.

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.

Zou H, Liu W, Wang X, Wang Y, Wang C, Qiu C J Immunother Cancer. 2024; 12(3).

PMID: 38443094 PMC: 11146396. DOI: 10.1136/jitc-2023-008450.

References

Yeh P, Dickinson M, Ftouni S, Hunter T, Sinha D, Wong S . Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes. Blood. 2017; 129(12):1685-1690. DOI: 10.1182/blood-2016-09-740308. View

Zhao P, Qin J, Liu W, Zhu Q, Fan T, Xiao H . Using circulating tumor DNA to monitor myelodysplastic syndromes status. Hematol Oncol. 2019; 37(4):531-533. PMC: 6900042. DOI: 10.1002/hon.2649. View

Ruan M, Liu L, Qi B, Chen X, Chang L, Zhang A . Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML. Front Oncol. 2021; 11:666470. PMC: 8377768. DOI: 10.3389/fonc.2021.666470. View

Nakamura S, Yokoyama K, Shimizu E, Yusa N, Kondoh K, Ogawa M . Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS. Blood. 2019; 133(25):2682-2695. DOI: 10.1182/blood-2018-10-880690. View

Short N, Patel K, Albitar M, Franquiz M, Luthra R, Kanagal-Shamanna R . Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia. Blood Adv. 2020; 4(8):1670-1677. PMC: 7189293. DOI: 10.1182/bloodadvances.2019001156. View